This study identified an increased risk of lymphoid malignancy in Shwachman-Diamond syndrome with an observed risk 38-fold higher than expected based on population data. Increased toxicity was observed with standard therapies in patients with SDS.

Subjects:
Lymphoid Neoplasia
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025

Article PDF first page preview

First page of Lymphoid Malignancies in patients with Shwachman-Diamond Syndrome
You do not currently have access to this content.
Sign in via your Institution